A phase II dose-ranging study of histamine dihydrochloride (MAXAMINE®) and interferon-α-2b as a new therapy for chronic hepaitits C: 12-Week interim analysis

✍ Scribed by Y. Lurie; M. Beer-Gabel; S.D. Malnick; S. Hyle; K.R. Gehlsen

• Book ID: 119526066
• Publisher: Elsevier Science
• Year: 2000
• Tongue: English
• Weight: 153 KB
• Volume: 32
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/s0168-8278(00)80731-x